DISEASE ACTIVITY AND CLINICAL RESPONSE EARLY IN THE COURSE OF TREATMENT PREDICT LONG-TERM OUTCOMES IN PSORIATIC ARTHRITIS PATIENTS TREATED WITH CERTOLIZUMAB PEGOL
Author(s):
Mease, P.J.; Fleischmann, R.; Davies, O.; Nurminen, T.; Heijde, D. van der
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-06-30
Language
English
Is part of
Annals of the Rheumatic Diseases (2014), Vol. 73, p. 741-741
